Nasal Drug Delivery Technology Market Analysis: Major Players, Lucrative Segments And Top Geographies
13 Jun, 2023
The global nasal drug delivery technology market size is expected to grow from $72.16 billion in 2022 to $77.42 billion in 2023 at a compound annual growth rate (CAGR) of 7.29%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global nasal drug delivery technology market size is expected to reach $101.49 billion in 2027 at a CAGR of 7%.
Global Nasal Drug Delivery Technology Market Key Driver
The rising prevalence of chronic diseases is projected to take the nasal medication delivery technology industry ahead. Chronic diseases are ailments that persist a year or longer and necessitate continuing medical attention, impede everyday activities, or both. Nasal medication delivery technologies are utilised in the treatment of chronic rhinosinusitis to increase bacterial biofilm or mucociliary clearance due to the complicated nature of the nasal cavity via a therapeutic nasal cavity strategy.
Get a sample of the global nasal drug delivery technology market reportGlobal Nasal Drug Delivery Technology Market Segments
The global nasal drug delivery technology market is segmented:
1) By Dosage Form: Nasal Spray, Nasal Drops, Nasal Gels And Ointments, Nasal Powders, Other Dosage Forms
2) By Container Type: Pressurized Containers, Non-Pressurized Containers
3) By Therapeutic Application: Allergic And Non-Allergic Rhinitis, Nasal Congestion, Asthma, Vaccination, Other Therapeutic Applications
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
5) By End User: Home Care Settings, Hospitals
6) By Geography: The regions covered in the nasal drug delivery technology market report are Asia-Pacific, Western Europe, Eastern Europe,North America, South America, Middle East, and Africa. Among these regions, North America accounts for the largest share in the global nasal drug delivery technology market.
Major Nasal Drug Delivery Technology Industry Players
AptarGroup Inc., Becton, Dickinson and Company, GlaxoSmithKline Plc, Johnson & Johnson Private Limited, Novartis AG, Pfizer Inc., 3M Co., Cadila Pharmaceuticals, Neurelis Inc., OptiNose Inc., Bausch Health Companies Inc., Naveh Pharma Ltd., Teva Pharmaceutical Industries Ltd., Consort Medical plc, Douglas Pharmaceuticals Ltd., ENT Technologies Pty. Ltd.
Get the full global nasal drug delivery technology market report
Nasal Drug Delivery Technology Market Overview
The nasal drug delivery technology refers to administering pharmaceuticals through the nasal cavity to attain therapeutic drug levels in the blood as quickly as possible and the potential for direct drug delivery to the brain via the olfactory neurons. Nasal drug delivery methods circumvent the blood-brain barrier (BBB) and undergo minimal hepatic and intestinal processing.
Nasal Drug Delivery Technology Global Market Report 2023 provides data on the global nasal drug delivery technology market such as market size, growth forecasts, segments and geographies, competitive landscape including leading competitors’ revenues, profiles and market shares. The nasal drug delivery technology market report identifies opportunities and strategies based on market trends and leading competitors’ approaches.